Abstract:Since its inception more than 20 years ago with highthroughput parallel synthesis for oligonucleotides and peptides, synthetic combinatorial methods have fundamentally advanced the ability to synthesize and screen large numbers of compounds because of improvements made in technology, instrumentation, and library design strategies. This discipline was readily accepted initially and is now an embedded component of the drug discovery process worldwide. While there are a range of combinatorial approaches, the use of mixture-based libraries made up of tens of thousands to billions of compounds is the approach that enables the most rapid and economical acquisition of chemical and biological information. Mixture-based libraries represent powerful tools that can be used for the identification of active individual compounds for a wide range of important targets, as reviewed. In the past decade, such approaches have been expanded to include the synthesis of low molecular weight acyclic and heterocyclic compounds. As with most innovations, synthetic combinatorial methods developed for the synthesis and screening of mixture-based libraries were slow to gain acceptance because of the conceptual distance between these approaches and the traditional methods previously used in the pharmaceutical industry. This was, and is, especially true for mixture-based libraries composed of tens of thousands to billions of different compounds, but such methods are now being used by an increasing number of groups for the identification of highly active, novel compounds in research and drug discovery programs. Mixture-based libraries are systematically arranged mixtures of synthetic compounds having both defined and mixture positions of diversity. This permits information to be gathered regarding both the activity and importance of every functionality at each position of the library. Post synthetic chemical modification of such existing mixturebased libraries using the “libraries from libraries” approach now enables the ever-increasing generation of low molecular weight compounds. Thus, for the last 16 years, we have successfully used this approach for the design and the generation of a range of peptidomimetic and small molecule libraries from resin-bound polyamides. We have also used this approach combining solidand solution-phase synthesis methods for the synthesis of a nitrosamine library and a platinum tetraamine coordination complex library. The power of synthetic mixture-based combinatorial libraries lies in their ability to accelerate the acquisition of information regarding specific functionalities at each variable position in the library that determines the activity of a specific chemical scaffold or pharmacophore. Another advantage of mixture-based libraries resides in the very high densities of compounds that can be synthesized in narrow areas of chemical space. When compared to existing high-throughput screening (HTS) programs, in which tens of thousands of individual compounds are screened against therapeutically important targets, millions of compounds formatted as mixtures can be examined using substantially less material and at much lower time/labor economics than if these same mixture-based diversities were made and screened as individual compounds. This unique combinatorial library approach can be applied to virtually any existing bioassay for the identification of novel ligands. For example, a novel, highly active tetrapeptide agonist for the κ-opioid receptor was identified from a positional scanning library of 6.25 * To whom correspondence should be addressed. Phone: 858-455-3805. Fax: 858-455-3804. E-mail: rhoughten@tpims.org. † Torrey Pines Institute for Molecular Studies. ‡ University of Arizona. § PsychoGenics, Inc. | Carnegie Mellon University. ⊥ Current address: College of Pharmaceutical Science, Zijin Campus, Zhejiang University, Hangzhou 310058, P. R. China. J. Comb. Chem. 2008, 10, 3–19 3

Strategies and techniques for identification of novel bioactive compounds--CHI's second annual conference. 7-9 October 1998, Zurich, Switzerland

10th annual drug discovery technology(®) europe and infotechpharma(®) conference

Phytochemicals in Drug Discovery-A Confluence of Tradition and Innovation

Abstract Wrk2-04: Virtual screening of ultra-large chemical spaces for novel chemotype discovery

Recent advances and method development for drug target identification

Artificial intelligence for natural product drug discovery

Conference report: emerging technology for bioanalysis in the next decade

Natural Products for Drug Discovery in the 21st Century: Innovations for Novel Drug Discovery

Augmenting Hit Identification by Virtual Screening Techniques in Small Molecule Drug Discovery

Virtual Screening on Natural Products for Discovering Active Compounds and Target Information

An Integrated Biochemoinformatics System for Drug Discovery

Concepts and technologies for tracking bioactive compounds in natural product extracts: generation of libraries, and hyphenation of analytical processes with bioassays

Hit me with your best shot: Integrated hit discovery for the next generation of drug targets

Recent Developments in Structure-Based Virtual Screening Approaches

Drug Discovery Summit: 14 th Swiss Course on Medicinal Chemistry

Strategies for the Use of Mixture-Based Synthetic Combinatorial Libraries: Scaffold Ranking, Direct Testing in Vivo, and Enhanced Deconvolution by Computational Methods

Recent advances in natural product discovery.

State-of-the-art technology in modern computer-aided drug design

Overview of Recent Strategic Advances in Medicinal Chemistry

Compound Libraries: Recent Advances and Their Applications in Drug Discovery.

Drug Discovery And Development Via Synthetic Biology